Ken Ando

6PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 03, 2024
Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study.

Noriyuki Okonogi, Keisuke Tsuchida, Ken Ando

|Feb 25, 2023
Association between Tumor Mutational Burden, Stromal CD8+ Tumor-Infiltrating Lymphocytes, and Clinical Factors in Cervical Cancers Treated with Radiotherapy.

Hanguang Ruan, Takahiro Oike, Hiro Sato

|Jan 05, 2023
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer.

Naoya Murakami, Miho Watanabe, Takashi Uno

|Jan 11, 2022
Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.

Tae Oike, Yoshihito Sekiguchi, Yuya Yoshimoto

|Jun 02, 2021
Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix.

Noriyuki Okonogi, Ken Ando, Kazutoshi Murata

|Sep 18, 2018
Tumor-specific CD8-positive T cell-mediated antitumor immunity is implicated in the antitumor effect of local hyperthermia.

Ken Ando, Yoshiyuki Suzuki, Takuya Kaminuma

Pageof 1

Frequent Collaborators

5 joint publications

Tatsuya Ohno

3 joint publications

Noriyuki Okonogi

2 joint publications

Kazutoshi Murata

2 joint publications

Keisuke Tsuchida